What is Asthma Sinus Allergy Program?
Asthma Sinus Allergy Program LLC operates within the Physicians Clinics industry, focusing on specialized respiratory and allergic conditions. With a team of 5 to 9 employees and an estimated revenue between $1 million and $5 million, the company is positioned to leverage its recent capital injection for growth and enhanced service offerings in the medical field.
How much funding has Asthma Sinus Allergy Program raised?
Asthma Sinus Allergy Program has raised a total of $58K across 1 funding round:
Debt
$58K
Debt (2021): $58K with participation from PPP
Key Investors in Asthma Sinus Allergy Program
PPP
Public-Private Partnership
What's next for Asthma Sinus Allergy Program?
The recent influx of expansion capital signals a pivotal moment for Asthma Sinus Allergy Program. This funding is expected to fuel strategic initiatives aimed at scaling operations, potentially expanding service reach, and enhancing diagnostic or treatment capabilities. The company's trajectory suggests a focus on solidifying its market position and capitalizing on opportunities within the specialized healthcare services domain.
See full Asthma Sinus Allergy Program company page
